# FindCure Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/findcure-biosciences

- Industry: Biotechnology
- Headquarters: Zhongshan, China
- Website: www.findcure-bio.com
- Total disclosed funding: $14M
- Latest round: Series B (Feb 14, 2026)
- Investors on record: 6

## About

Based in Beijing, China, and founded in 2019, FindCure Biosciences (Zhongshan) Co., Ltd., trading as FindCure Biosciences, is a biotechnology company whose primary business is the development of new anti-cancer drugs. It has established an R&D laboratory in Zhongshan. Some enterprises, such as BioDuro, Pharmaron, and KYinno, have cooperated with the company. In August 2020, the company set up a subsidiary in Shenzhen. In February 2026, FindCure Biosciences raised over 100 million in series B funding.
FindCure Biosciences focuses on drug discovery and development targeting signaling pathways and immunotherapy, including small molecule targeted drugs, large molecule proteins and antibody drugs with independent intellectual property rights. The company's products, selective Axl inhibitor FC084 and type II met inhibitor FC413, have both entered the phase I clinical stage, and PI3K? inhibitor FC919 is undergoing IND filing. The products can be used in curing stomach and lung cancer.
The company's revenue is generated by providing cancer drug development service.
The series B funds will be mainly used for the construction of the nuclear drug platform and the advancement of clinical trials, helping the company enter a new stage of development.

## Funding rounds

- Series B, Feb 14, 2026, $14M — Hecheng Capital, Renxi Fund, Zhongshan Torch Electronics Industry Fund Management
- Series A, Sep 1, 2023 — Zhongshan Torch Hi-Tech Industrial Development Zone Industrial Development, Hecheng Capital, Yishang Huicheng Investment, Renxi Fund, Dilianxing

## Investors

- Zhongshan Torch Hi-Tech Industrial Development Zone Industrial Development — Series A
- Hecheng Capital (https://capitalatlas.ai/funds/hecheng-capital) — Series A, Series B
- Yishang Huicheng Investment (https://capitalatlas.ai/funds/yishang-huicheng-investment) — Series A
- Renxi Fund — Series A, Series B
- Dilianxing — Series A
- Zhongshan Torch Electronics Industry Fund Management (https://capitalatlas.ai/funds/zhongshan-torch-electronics-industry-fund-management) — Series B